Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells

International Angiology

Volumn 15, Issue 2, 1996, Pages 93-99

  Warner, T D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Blood cells; Endothelium, vascular; Platelets

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; PROSTACYCLIN;

ARTICLE; BLOOD PRESSURE; ENDOTHELIUM CELL; HYPERTENSION; NEUTROPHIL; NONHUMAN; SMOOTH MUSCLE TONE; SUBARACHNOID HEMORRHAGE; THROMBOCYTE; THROMBOCYTE ADHESIVENESS; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

BLOOD PLATELETS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; MUSCLE, SMOOTH, VASCULAR; NEUTROPHILS; NITRIC OXIDE;

EID: 0029939683     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Needleman P, Turk J, Jakschik BA, Morrison RA, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
2. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993;268:12231-4.
3. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T. et al. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992;89:444-8.
4. De Nucci G, Gryglewski RJ, Warner TD, Vane JR. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988;85:2334-8.
5. D'Orleans-Juste P, Mitchell JA, Wood EG, Hecker M, Vane JR. Comparison of the release of vasoactive factors from venous and arterial cultured endothelial cells. Can J Physiol Pharmacol 1992;70:687-94.
6. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985;227:1477-9.
7. Carosi JA, McIntire LV, Eskin SG. Modulation of secretion of vasoactive materials from human and bovine endothelial cells by cyclic strain. Biotechnol Bioeng 1994;43:615-21.
8. Korenaga R, Ando J, Tsuboi H, Yang W, Sakuma I, Toyo-oka T et al. Laminar flow stimulates ATP- and shear stress-dependent nitric oxide production in cultured bovine endothelial cells. Biochem Biophys Res Commun 1994;198:213-9.
9. Macarthur H, Warner TD, Wood EG, Corder R, Vane JR. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 1994;200:395-400.
10. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-8.
11. Gnitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol 1990;101:10-12.
12. 2) on platelet adhesion to rabbit arterial subendothelium. Prostaglandins 1978;16:17-22.
13. Moncada S. Biological importance of prostacyclin. Br J Pharmacol 1982;76:3-31.
14. Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
15. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium, Lancet 1987;2:1057-8.
16. Sneddon JM, Vane JR. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988;85:2800-4.
17. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
18. Warner TD, Mitchell JA, Sheng H, Murad F. Effects of cyclic GMP on smooth muscle relaxation. Adv Pharmacol 1994;26:171-94.
19. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368:850-3.
20. Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639-46.
21. Lidbury PS, Antunes E, de Nucci G, Vane JR. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation. Br J Pharmacol 1989;98:1275-1280.
22. Kubes P, Suzuki, M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
23. Ma X, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-12.
24. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:H1269-75.
25. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990;4:3355-9.
26. Lefer AM, Ma X. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb 1993;13:771-6.
27. Niu X-F, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cells adhesion to neutrophils. Circ Res 1994;74:1133-40.
28. 2-analogues and an NO (EDRF)-donor: a comparison between platelets of healthy and diabetic subjects. Platelets 1994;5:45-52.
29. Korbut R, Lidbury PS, Vane JR. Prolongation of fibrinolytic activity of tissue plasminogen activator by nitro-vasodilators. Lancet 1990;335:669.
30. Vidal MJ, Romero JC, Vanhoutte PM. Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol 1988;149:401-2.
31. Morton JJ, Beattie EC, Speirs A, Gulliver F. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens 1993;11:1083-8.
32. Deng LY, Thibault G, Schiffrin EL. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries of the rat. Clin Exp Hypertens 1993;15:527-37.
33. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994;14:753-9.
34. Barret ML, Willis AL, Vane JR. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). Agents Actions 1989;27:488-91.
35. Garg UC, Hassid A. Nitric-oxide generating vasodilators and 8-bromo cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83: 1774-7.
36. Willis AL, Smith DL, Vigo C. Suppression of principal atherosclerotic mechanisms by prostacyclins and other eicosanoids. Prog Lipid Res 1986;25:645-66.
37. Willis AL, Smith DL, Vigo C, Kluge AR Effects of prostacyclin and orally stable mimetic agent RS-93427-007 on basic mechanisms of atherogenesis. Lancet 1987;2:682-3.
38. Hajar DP. Prostaglandins and cyclic nucleotides: modulation of arterial cholesterol metabolism. Biochem Pharmacol 1985;34:295-300.
39. Vane JR, Botting RM. Impact of risk factors on the endothelium. Cardiovasc Risk Factors 1994;4:108-21.
40. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroid anti-inflammatory drugs as inhibitors of constitutive and inducible cyclo-oxygenase. Proc Natl Acad Sci USA 1993; 90:11693-7.
41. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995;114:1335-42.
42. Eldor A, Falcone DJ, Hajjar D, Minick R, Weksler BB. Recovery of prostacyclin production by de-endothelialized rabbit aorta. J Clin Invest 1981;67:735-41.
43. Douglas SA, Vickery-Clarke LM, Ohlstein EH. Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction. Eur J Pharmacol 1994;255:81-9.
44. Rubanyi GM. Endothelium-derived vasoconstrictor factors. In: Ryan US editor, Endothelial Cells. Boca Raton, FL:CRC Press 1988;3:61-74.
45. Shimada K, Takahashi M, Tanzawa K. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 1994;269:18275-8.
46. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: a membrane-bound metal loprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994;78:473-85.
47. Milner P, Bodin P, Loesch A, Burnstock G. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 1990;170:649-56.
48. Vemulapalli S, Chiu PJS, Griscti K, Brown A, Kurowski S, Sybertw EJ. Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur J Pharmacol 1994;257:95-102.
49. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
50. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-5.
51. Warner TD. Characterization of endothelin synthetic pathways and receptor subtypes: physiological and pathophysiological implications. Eur Heart J 1993;14 (Suppl I):42-7.
52. Warner TD, Battistini B, Doherty AM, Corder R. Endothelin receptor antagonists: actions and rationale for their development. Biochem Pharmacol 1994;48:625-35.
53. Battistini B, D'Orleans-Juste P, Sirois P, Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993;68:600-28.
54. Huggins JP, Pelton JT, Miller RC. The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmac Ther 1993;59:55-123;
55. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry pharmacology, physiology and pathophysiology. Pharmacol Rev 1994;46:325-415.
56. Thiemerman C, Lidbury PS, Thomas GR, Vane JR. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anaesthetized rabbit. J Cardiovasc Pharmacol 1989;13 (Suppl 5):S138-41.
57. Warner TD. Endothelin receptor antagonists. Cardiovasc Drug Rev 1994;12:105-22.
58. Thiemermann C, May GR, Page CP, Vane JR. Endothelin-1 inhibits platelet aggregation in vivo: a study with indium labelled platelets. Br J Pharmacol 1990;99:303-8.
59. Filep JG, Herman F, Battistini B, Chabrier P-E, Braquet P, Sirois P. Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin. J Cardiovasc Pharmacol 1991;17(Suppl 7):S216-8.
60. Korbut R, Lidbury PS, Thomas GR, Vane JR. Fibrinolytic activity of endothelin-3. Thromb Res 1989; 55:797-9.
61. Achmad TH, Rao GS. Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem Biophys Res Commun 1992;189:994-1000.
62. Bath PM, Mayston S, Martin JF. Endothelin and PDGF do not stimulate peripheral blood monocyte chemotaxis, adhesion to endothelium, and Superoxide production. Exp Cell Res 1990;187-339-42.
63. Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet activating factor. Br J Pharmacol 1991;104:797-804.
64. Valentin JP, Gardener DG, Wiedemann E, Humphreys MH. Modulation of endothelin effects on blood pressure and hematocrit by atrial natriuretic factor. Hypertension 1991;17:864-9.
65. Douglas SA, Ohlstein EH. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1993;22(Suppl 8):S371-3.
66. Douglas SA, Louden C, Vickery-Clarke LM, Storer BL, Hart T, Feuerstein GZ et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 1994;75:190-7.
67. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993;191:1081-8.
68. Boulanger CM, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-90.
69. Warner TD, Schmidt HHHW, Murad F. Interactions of endothelin and EDRF in bovine native endothelial cells: selective effects of endothelin-3. Am J Physiol 1992;262:H1600-5.